Anton RF, O'Malley SS, Mann KF, Silverman BL. New Reduced Drinking Goals in Alcohol Pharmacotherapy Trials-A Novel Public-Private Effort and FDA Approval Process. JAMA Psychiatry. 2025 Sep 17. [Epub ahead of print]
Lenz B, Derntl B. Sex-sensitive and gender-sensitive care for patients with mental disorders. Lancet Psychiatry. 2025 12(4):244-246. Epub 2024 Oct 24.
Nayman S, Niedtfeld I, Lenz B, Karabatsiakis A, Schmahl C, Kühner C. Menstrual Cycle Dynamics in Mental Health Demand new Approaches in Psychotherapy and Digital Health. Psychother Psychosom. 2025 Sep 18. [Epub ahead of print] :1-5.
Witkiewitz K, Anton RF, O'Malley SS, Hasin DS, Silverman BL, Aldridge A, Mann KF, Alcohol Clinical Trials Initiative (ACTIVE Group) . Reductions in World Health Organization Risk Drinking Levels as a Primary Efficacy End Point for Alcohol Clinical Trials: A Review. JAMA Psychiatry. 2025 Sep 17. [Epub ahead of print]
Zimmermann S, Teetzmann A, Baeßler J, Schreckenberger L, Zaiser J, Pfisterer M, Stenger M, Bach P. Acute cannabidiol administration reduces alcohol craving and cue-induced nucleus accumbens activation in individuals with alcohol use disorder: the double-blind randomized controlled ICONIC trial. Mol Psychiatry. 2025 30(6):2612-2619. Epub 2024 Dec 12.